RICERCA ITALIANA     

Bibliografia

1. Angrill J, Celis R, Arancibia F, Bauer TT, Xaubet A, González J, Torres A. Bacterial colonization in patients with bronchiectasis: prevalence and comparison of diagnostic techniques. Am J Respir Crit Care Med 1999; 159: A559
2. Burrows B, Earle RH. Course and prognosis of chronic obstructive lung disease: a prospective study of 200 patients. N Engl J Med 1969; 280: 397-404.
3. Sethi S, Muscarella K, Evans N, Klingman KL, Grant JB, Murphy TF. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 2000; 118: 1557-1565.
4. Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418-1422.
5. Donaldson GC, Seemungal TAR, Bhomik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847-852.
6. Staykova T, Black P, Chacko E, Ram FSF, Poole P.. Prophylactic antibiotic therapy for chronic bronchitis (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.
7. http://www.fda.gov/ohrms/dockets/ac/02/slides/3837s1_09_Thompson/sld034.htm
8. Monsó E, Ruiz J, Rosell A, Manterola J, Fiz J, Morera J, et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995; 152: 1316-1320.
9. Miravitlles M. Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?. Eur Respir J 2002; 20 (Suppl 36): 9s-19s.
10. Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 2000; 109: 288-295.
11. Wilkinson TMA, Patel IS, Wilks M, et al. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonay disease. Am J Respir Crit Care Med 2003; 167: 1090-1095.
12. Patel IS, Seemungal TAR, Wilks M, et al. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002; 57: 759-764.
13. Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000; 55(7): 629-630
14. Angrill J, Agustì C, De Celis R, et al. Bronchial Inflammation and Colonization in Patients with Clinically Stable Bronchiectasis. Am J Respir Crit Care Med 2001;164 (9):1628-1632
15. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Resp Crit Care Med 2001;163: 1693-1722
16. Bucchioni E, Kharitonov SA, Allegra L, Barnes PJ. High levels of interleukin-6 in the breath condensate of patients with COPD. Resp Med 2003; 17(12): 1299-1302;
17. Corradi M, Rubinstein I, Andreoli R. Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167(10): 1380-6
18. Carpagnano GE, Barnes PJ, Geddes DM. Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am J Respir Crit Care Med 2003; 167(8): 1109-1112
19. Bucchioni E, Csoma Z, Allegra L, Chung KF, Barnes PJ, Kharitonov SA. Adenosine 5-monophosphate increases levels of leukotrienes in breath condensate in asthma. Resp Med 2004; 98(7).651-655
20. Von Pohle WR, Anholm JD, McMillan J. Carbon dioxide and oxygen partial pressure in expiratory water condensate are equivalent to mixed expired carbon dioxide and oxygen. Chest 1992; 101: 1601-1604
21. Wilkins MR, Williams KL, Appel RD, et al. Proteome Research: New Frontiers in Functional Genomics. Berlin, Germany: Springer-Verlag; 1997.
22. Scheideler L, Manke HG,Schwulera U, et al. Detection of non-volatile macromolecules in breath. A possible diagnostic tool? Am RevRespir Dis. 1993;148:778–784.
23. Mutlu GM, Garey KW, Robbins RA, et al. Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med.2001;164:731–737.
24. Griese M, Noss J, von Bredow C. Protein pattern of exhaled breath condensate and saliva. Proteomics. 2002;2:690–696.
25. Gianazza E. Allegra L. Bucchioni E., Eberini I., Puglisi L., Blasi F., Terzano C., Wait R., Sirtori C. Increased keratin content detected by proteomic analysis of exhaled breath condensate from healthy persons who smoke. Am J Med 2004;117:51-4
26. G Davies, R Wilson Prophylactic antibiotic treatment of bronchiectasis with azithromycin Thorax 2004;59:540–541;
27. K W Tsang, K C Tan, P L Ho, G C Ooi, J C Ho, J Mak, G L Tipoe, C Ko, C Yan, W K Lam,M Chan-Yeung. Inhaled fluticasone in bronchiectasis: a 12 month study. Thorax 2005;60:239–243
28. 28. Webb W, Muller N, Naidich D: HRCT of the lung III Ed Lippincott, Philadelphia; 2001
29. Luyt CE, Guerin V, Combes A, Trouillet JL, Ayed SB, Bernard M, Gibert C, Chastre J. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia Am J Respir Crit Care Med. 2005 Jan 1;171(1):48-53.
30. Pizzichini E, et al. Indices of airway inflammation in induced sputum : reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154: 308-317.
31. Murray TJ, Washington JA. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clini Proc 1975; 50: 339-44.
32. Patel IS, Vlahos I, Wilkinson TM, Lloyd-Owen SJ, Donaldson GC, Wilks M, Reznek RH, Wedzicha JA Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004 Aug 15;170(4):400-7